Influenza Diagnostics Market

According to the analysis of Market Research Future (MRFR), the global influenza diagnostics market is anticipated to register a moderate CAGR of 7.80% to acquire a USD 954.512 million by 2023.

Influenza is a transmittable respiratory infection triggered by several flu viruses. Pandemics influenza is noted as a new flu virus strain that can quickly spread from person to person. Every year recurrent flu affects millions of people and results in thousands of hospitalizations and flu-related deaths. Growing geriatric patient population, the introduction of quadrivalent influenza vaccines, and growing disease awareness drive the growth of the global Influenza Diagnostics Market Share. However, stringent regulations may hinder the growth of the market over the evaluation period.

Segmental Analysis

The global market for molecular diagnostics companies is segmented based on type, tests, and end-users.

·         The types of influenza infections in the market are type A flu, Type B flu, and type C flu. The type-A flu segment is anticipated to lead the market and record a considerable CAGR to acquire USD 954.512 million by the end of the evaluation period. These viruses were majorly responsible for large annual epidemics in the past. Nevertheless, the type B flu segment is anticipated to exhibit the highest CAGR of 8.66% over the assessment period. The increase in government initiatives to reduce the prevalence of influenza, increasing awareness among consumers and the augmented risk of contracting influenza are anticipated to drive market growth over the forecast period.

·         The various kinds of tests available for the diagnosis of influenza are traditional diagnostic tests and molecular diagnostic tests.

·         Based on end-users, the influenza diagnostics market has been segmented into hospitals and clinical laboratories and point of care testing.

Key Players

The key players identified in the global Influenza Diagnostics Market companies are 

·         Abbott,

·         Analytik Jena AG,

·         Becton,

·         Biocartis,

·         Cepheid,

·         bioMérieux Inc,

·         DiaSorin S.p.A.,

·         Dickinson and Company,

·         GenMark Diagnostics, Inc.,

·         Luminex Corporation,

·         F. Hoffmann-La Roche Ltd,

·         Meridian Bioscience, Inc.,

·         SA Scientific,

·         Quidel Corporation,

·         Thermo Fisher Scientific Inc.

Regional Analysis

Based on the region, the global influenza diagnostics market is analysed in the Americas, Europe, Asia Pacific, and the middle east and Africa.

The Americas (North America and Latin America) account for the largest market share and are likely to retain their lead over the forecast period. The market growth in this region is primarily attributed to the growing prevalence of influenza among the geriatric population, and the availability of advanced healthcare facilities in this region. 

The European market for influenza diagnostics is anticipated to be the second largest during the review period. The growing number of pharmaceutical companies exporting their products abroad or within Europe is projected to contribute to market growth. The factors accountable for the market growth in this region are an increase in disease awareness among consumers, initiatives taken by governmental and advisory bodies to ensure vaccination procedures against influenza, and a surge in the size of the aging population. The influenza diagnostics market in Europe is predicted to be impacted by several other factors the review period, such as the numerous favorable factors such as the introduction of innovative technologies, affordable pricing, reimbursement, unmet medical necessities in certain regions, and strong clinical pipeline.

Asia-Pacific is assessed to be the fastest growing market owing to the developing healthcare infrastructure. Due to the growing prevalence of other diseases such as cardiovascular, endocrinology, lymphatic systems, and respiratory disorders, the market growth for influenza diagnostics is expected to rise over the evaluation period. The increasing efforts taken by the governments to increase consumer awareness, provide suitable vaccines, and fulfil the unmet needs in certain countries, is substantially driving the market growth over the assessment period.

The Middle East and Africa region (MEA) are expected to acquire the smallest market share in the forecast period, owing to the weak healthcare sector in certain parts of Africa. The Middle East is likely to contribute to most of the market share registers from this region.

Table of content

1 Executive Summary

2 Market Introduction

2.1 Definition 18

2.2 Scope Of The Study 18

2.3 Assumptions & Limitations 18

2.3.1 Assumptions 18

2.3.2 Limitations 18

2.4 Market Structure 19

3 Research Methodology

3.1 Research Process 20

3.2 Primary Research 21

3.3 Secondary Research 21

3.4 Market Size Estimation 22

3.5 Forecast Model 23

TOC will be continue

About US:

Market Research Future (MRFR) enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013